Changes in butyrylcholinesterase activity and serum lipids after oxprenolol and glibenclamide treatments in non-diabetic rats

Arzneimittel-Forschung/Drug Research

Volumn 56, Issue 2, 2006, Pages 64-69

  Bradamante, Vlasta ^a   Krnić, Žarka ^b   Zrinski, Renata ^c   Konjevoda, Paško ^d   Reiner, Željko ^c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b PLIVA CROATIA LTD   (Croatia)

^c KBC Zagreb   (Croatia)

^d RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Butyrylcholinesterase; CAS 10238 21 8; CAS 6452 72 7; Glibenclamide, effects on plasma lipids, rat; Lipid reducers; Oxprenolol, effects on plasma lipids, rat

Indexed keywords

ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CHOLINESTERASE; GLIBENCLAMIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; OXPRENOLOL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIVER; NONHUMAN; RAT;

EID: 33645107194     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296703     Document Type: Article

References (35)

1. Kutty, K. M., Biological function of cholinesterase. Clin. Biochem. 13, 239 (1980)
2. Soreq, H., Zamir, R., Zevin-Sonkin, D., Zakut, H., Human cholinesterase genes localized by hybridation to chromosomes 3 and 16. Hum. Genet. 77, 325 (1987)
3. Kutty, K. M., Annanpurna, V., Prabhakaran, V., Pseudocholinesterase: A protein with functions unrelated to its name. Biochem. Soc. Trans. 7, 555 (1989)
4. Ballantyne, F. C., Histochemical and biochemical aspects of cholinesterase activity of adipose tissue, Arch. Int. Pharmacodyn. 173, 348 (1968)
5. Katz, R. L., Ryan, J. F., Neuromuscular effects of suxamethonium in man. Br. J. Anaesth. 41, 381 (1969)
6. Kalow, W., Hydrolysis of local anesthetics by human serum cholinesterase. J. Pharmacol. Exp. Ther. 104, 122 (1952)
7. Kunec-Vajic, E., Bradamante, V., Uroic, B., The effect of local anesthetics and phenothiazine derivatives on cholinesterase, investigated by a chemiluminescence method. Acta Pharm. Jugosl. 35, 133 (1985)
8. Brown, S. S., Kalow, W., Pilz, W. et al., The plasma cholinesterase: a new perspective. Adv. Clin. Chem. 22, 1 (1981)
9. Wetstone, H. J., LaMotta, R. V., Bellucci, A. et al., Studies of cholinesterase activity. V. Serum cholinesterase in patients with carcinoma. Ann. Intern. Med. 52, 102 (1960)
10. Bradamante, V., Kunec-Vajic, E., Lisic, M. et al., Plasma cholinesterase activity in patients during therapy with dexamethasone or prednisone. Eur. J. Clin. Pharmacol. 36, 253 (1989)
11. Kutty, K. M., Redheendran, R., Murphy, D., Serum cholinesterase: Function in lipoprotein metabolism. Experientia 33, 420 (1977)
12. Magarian, E. O., Dietz, A. J., Correlation of cholinesterase with serum lipids and lipoproteins. J. Clin. Pharmacol. 27, 810 (1987)
13. Annapurna, V., Senciall, I., Davis, A. J. et al., Relationship between serum pseudocholinesterase and triglycerides in experimentally induced diabetes mellitus in rats. Diabetologia 34, 320 (1991)
14. Abbott, C. A., Mackness, M. I., Kumar, S. et al., Relationship between serum cholinesterase activity. Hypertriglyceridemia and insulin sensitivity in diabetes mellitus. Clin. Sci. 85, 77 (1993)
15. Chu, M. I., Fontaine, P., Kutty, K. M. et al., Cholinesterase in serum and low density lipoprotein of hyperlipidemic patients. Clin. Chim. Acta 85, 55 (1978)
16. |16] Cucuiany, M., Popescu, T. A., Haragus, S. T., Pseudocholinesterase in obese and hyperlipemic subjects. Clin. Chim. Acta 22, 151 (1968)
17. Rustemeijer, C., Scheuten, J. A., Voerman, H. J. et al., Is pseudocholinesterase activity related to markers of triacylglycerol synthesis in Type II diabetes mellitus? Clin. Sci. 101, 29 (2001)
18. Kutty, K. M., Jain, R., Peper, C., Cholinesterase activity in the serum and liver of Zucker fat rats and controls. Nutr. Res. 4, 99 (1984)
19. Osada, J., Aylagas, H., Sanchez-Ramos, B. et al., Association between rat serum cholinesterase and some phospholipids components of lipoproteins in thioacetamide-induced hepatic injury. Toxicology 63, 245 (1990)
20. Van Brummelen, P., The relevance of intrinsic sympathomimetic activity for beta-blocker-induced changes in plasma lipids. J. Cardiovasc. Pharmacol. 5, (Suppl. 1), S51 (1983)
21. Ames, R. P., The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs. Drugs 32, 335 (1986)
22. Whittaker, M., Wicks, R. J., Britten, J. J., Studies on the inhibition by propranolol of some human erythrocyte membrane enzymes and plasma cholinesterase. Clin. Chim. Acta 119, 107 (1982).
23. Whittaker, M., Britten, J. J., Wicke, R. J., Inhibition of the plasma cholinesterase variants by propranolol. Br. J. Anaesth. 53, 511 (1981)
24. Krnic, Z., Bradamante, V., Effects of oxprenolol treatment on pseudocholinesterase and lipids in rats. Arzneim.-Forsch./Drug Res. 47, 910 (1997)
25. Baynes, C., Elkeles, R. S., Henderson, A. D. et al., The effects of glibenclamide on glucose homeostasis and lipoprotein metabolism in poorly controlled type 2 diabetes. Horm. Metab. Res. 25, 96 (1993)
26. Ellman, G. L., Courtney, K. D., Andres, V. et al., A new rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88 (1961)
27. Alkondon, M., Ray, A., Sen, P., Tissue cholinesterase inhibition by propranolol and related drugs. J. Pharm. Pharmacol. 38, 848 (1986)
28. Hellenbrecht, D., Muller, K. F., Beta-sympatholytics as non-specific inhibitors of serum cholin-esterase. Experientia. 29, 1255 (1973)
29. Ryhanen, R. J. J., Jauhianen, M. S., Laitinen, M. V. et al., The relationship between human serum pseudocholinesterase, lipoproteins, and apolipoproteins (APOHDL). Biochem. Med. 28, 241 (1982)
30. Day, J. L., Metcalfe, J., Simpson, N. et al., Adrenergic mechanisms in the control of plasma lipids in man. Am. J. Med. 76 (2A), 94 (1984)
31. Ferrara, L. A., Maritta, T., Scilla, A. et al., Effect of oxprenolol and metoprolol on serum lipid concentration. Eur. J. Clin. Pharmacol. 26, 331 (1984)
32. Rabkin, S. W., Mechanisms of action of adrenergic receptor blockers on lipids during antihypertensive drug treatment. J. Clin. Pharmacol. 33, 286 (1993)
33. Billingham, M. S., Hall, R. A., Simpson, S. et al., Lack of effect of glibenclamide, chlorpropamide and metformin on plasma cholesterol and HDL-cholesterol in non-diabetic rats. Horm. Metab. Res. 12, 340 (1980)
34. George, A. V., Augusti, K. T., Effects of long-term feeding of glibenclamide on normal rats. Experientia 32, 846 (1976)
35. Gaafar, K., Salama, S., El Batran, S., Studies on the glycemic and lipidemic effect of atenolol and propranolol in normal and diabetic rats. Arzneim.-Forsch./Drug Res. 44, 96 (1994)